🇺🇸 AMGN — Amgen Inc.

Healthcare Compra
← Volver

Precio actual

437,23 USD

Máx. histórico

447,03

10 días

Split 2:1 del 22/11/1999

Caída desde máximo

-2,19%

Rango 52 semanas

269,77 – 447,03

Variación hoy

-1,55%

Cierre anterior

444,12

Rango de hoy

435,01 – 441,66

Volumen hoy

1.656.089

Información
Nombre completo
Amgen Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
31.500
PER ⓘ
27,17 (puede no estar actualizado)
Dividend yield
2,31% (puede no estar actualizado)
Precio objetivo analistas
389,69 USD (puede no estar actualizado)
Primera cotización
17/06/1983
Precio actualizado
hace 3 días
Sobre la empresa

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Dividendos repartidos Total últimos 12 meses: 9,9400 USD · Yield: 2,27%
Fecha de pago Importe por participación
14/02/2019 1,4500 USD
15/11/2018 1,3200 USD
16/08/2018 1,3200 USD
16/05/2018 1,3200 USD
14/02/2018 1,3200 USD
16/11/2017 1,1500 USD
15/08/2017 1,1500 USD
15/05/2017 1,1500 USD
13/02/2017 1,1500 USD
14/11/2016 1,0000 USD
15/08/2016 1,0000 USD
13/05/2016 1,0000 USD
11/02/2016 1,0000 USD
12/11/2015 0,7900 USD
13/08/2015 0,7900 USD
Splits Registrados en el histórico de precios
Fecha Ratio
22/11/1999 2:1
01/03/1999 2:1
16/08/1995 2:1
11/09/1991 3:1
13/08/1990 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
09/08/1999 38,31 39,47 38,16 38,41 +0,49% 3,43% 6.693.000
06/08/1999 39,25 40,13 37,81 38,22 -3,47% 5,89% 8.360.200
05/08/1999 38,56 39,66 37,56 39,59 +2,76% 5,43% 7.244.000
04/08/1999 38,50 39,34 38,31 38,53 +0,57% 2,68% 9.716.400
03/08/1999 39,47 39,59 37,59 38,31 -2,70% 5,07% 11.616.400
02/08/1999 38,31 40,00 38,31 39,38 +2,44% 4,40% 14.186.400
30/07/1999 37,31 38,53 37,31 38,44 +4,41% 3,27% 8.459.200
29/07/1999 36,97 37,31 36,34 36,81 -1,92% 2,62% 7.693.200
28/07/1999 37,25 37,94 36,81 37,53 +0,67% 3,02% 6.957.400
27/07/1999 36,84 37,50 36,13 37,28 +2,14% 3,73% 7.423.800
26/07/1999 37,38 38,09 36,31 36,50 -3,15% 4,77% 8.972.800
23/07/1999 36,28 37,69 36,25 37,69 +4,42% 3,96% 7.032.400
22/07/1999 37,16 37,94 36,09 36,09 -3,35% 4,96% 8.933.400
21/07/1999 36,75 37,63 36,50 37,34 +2,31% 3,06% 9.234.600
20/07/1999 36,63 37,72 36,47 36,50 -0,60% 3,41% 12.654.400
19/07/1999 38,84 38,84 36,38 36,72 -5,39% 6,36% 11.274.800
16/07/1999 39,56 39,56 38,59 38,81 -1,58% 2,45% 8.631.000
15/07/1999 38,56 39,47 37,84 39,44 +2,27% 4,21% 14.162.200
14/07/1999 36,13 38,56 36,13 38,56 +6,65% 6,75% 15.053.600
13/07/1999 36,75 36,94 35,38 36,16 +9,05% 4,25% 28.820.600
12/07/1999 34,81 35,00 32,75 33,16 -4,33% 6,46% 16.756.600
09/07/1999 33,44 34,88 33,13 34,66 +5,62% 5,23% 17.447.200
08/07/1999 31,81 33,38 31,56 32,81 +4,48% 5,70% 18.080.000
07/07/1999 29,63 31,44 29,59 31,41 +6,46% 6,22% 10.323.600
06/07/1999 30,50 30,69 29,50 29,50 -3,18% 3,89% 8.425.800
02/07/1999 30,63 30,75 30,13 30,47 +0,10% 2,04% 5.258.200
01/07/1999 30,38 30,69 29,88 30,44 +0,00% 2,67% 6.218.600
30/06/1999 30,03 30,63 29,81 30,44 +1,56% 2,71% 10.646.400
29/06/1999 29,06 29,97 28,97 29,97 +3,01% 3,44% 12.618.000
28/06/1999 28,38 29,13 27,91 29,09 +4,02% 4,29% 9.544.600